Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

NCT03185988 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Targeted Therapy
HER2
Biliary Tract Cancer
Esophageal Squamous Cell Carcinoma
Colorectal Cancer

Interventions

DRUG: chemotherapy in combination with trastuzumab for arm1
DRUG: chemotherapy in combination with trastuzumab for arm2
DRUG: chemotherapy in combination with trastuzumab for arm3
DRUG: chemotherapy in combination with trastuzumab for arm4

Sponsor

Shen Lin